• Explore /
  • Poster
  • / Dose adjustment of axitinib based on AUC monitoring in sunitinib-refractory advanced renal cell carcinoma.

Dose adjustment of axitinib based on AUC monitoring in sunitinib-refractory advanced renal cell carcinoma.

Abstract Poster

Authors

null

Yuji Miura

Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan

Yuji Miura , Chiyo K. Imamura , Keita Uchino , Takeshi Kishida , Nobuaki Matsubara , Toshiaki Shinojima , Mototsugu Oya , Noboru Nakaigawa , Kenichi Yoshimura , Toshimi Takano , Yusuke Tanigawara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer

Sub Track

Kidney Cancer

Clinical Trial Registration Number

UMIN000009579

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS4598)

DOI

10.1200/jco.2014.32.15_suppl.tps4598

Abstract #

TPS4598

Poster Bd #

161B

Abstract Disclosures

Similar Posters

First Author: Sachdev P. Thomas

First Author: Patrick Bolan

First Author: Sike He

First Author: Arthur Geraud